Vaccinations

ANALYSIS of the difficulties in comparing vaccines

Wed, 2021-02-24 19:09 — mike kraft

Why COVID vaccines are so difficult to compare Despite the widespread roll-out of several vaccines, it could be months before they can be ranked. Heidi Ledford nature

Yusuff Adebayo Adebisi knows that a vaccine that offers 70% protection against COVID-19 could be a valuable tool against the coronavirus pandemic in Nigeria — especially if that vaccine is cheap and doesn’t have to be stored at extremely cold temperatures. But what if another vaccine — one that is more expensive to buy and to store — was 95% effective?

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about ANALYSIS of the difficulties in comparing vaccines
Log in or register to post comments

Moderna developing booster shot for coronavirus variants, boosts production target

Wed, 2021-02-24 17:42 — mike kraft

Moderna developing booster shot for new coronavirus variants, increases vaccine production target Moderna Inc said on Wednesday it is working with U.S. government scientists to study an experimental booster shot that targets a concerning new variant of the coronavirus, and has raised its global COVID-19 vaccine production goal for this year by 100 million doses. Julie Steenhuysen, Carl O’Donnell U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna developing booster shot for coronavirus variants, boosts production target
Log in or register to post comments

NIH to launch research into Covid long term effects, plus international roundup

Wed, 2021-02-24 13:16 — mike kraft

Roundup: NIH to study ‘long-haul’ virus symptoms

WASHINGTON (AP) — The National Institutes of Health is launching research to understand the causes and consequences of the lingering brain fog, breathing problems and malaise reported by many recovering COVID-19 patients.

Dr. Anthony Fauci says some studies have shown up to 30% of patients report symptoms that can endure for months, complicating their return to normal routines and work, and plunging many recovering patients into depression.

Fauci noted at a White House coronavirus briefing on Wednesday that work at NIH started this week thanks to more than $1 billion provided by Congress for COVID-related medical research. Government scientists are looking to enlist doctors and research institutions around the country in the effort to learn about “long-haul” COVID-19.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about NIH to launch research into Covid long term effects, plus international roundup
Log in or register to post comments

FDA says Johnson and Johnson vaccine provides protection against Covid, a step toward final decision

Wed, 2021-02-24 09:09 — mike kraft

FDA says J&J 1-dose shot prevents COVID; final decision soon

WASHINGTON (AP) — Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.

The Food and Drug Administration’s scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. The agency also said J&J’s shot — one that could help speed vaccinations by requiring just one dose instead of two — is safe to use.

That’s just one step in the FDA’s evaluation of a third vaccine option for the U.S. On Friday, the agency’s independent advisers will debate if the evidence is strong enough to recommend the long-anticipated shot. Armed with that advice, FDA is expected to make a final decision within days. ...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA says Johnson and Johnson vaccine provides protection against Covid, a step toward final decision
Log in or register to post comments

AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official

Tue, 2021-02-23 18:49 — mike kraft

Exclusive: AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official AstraZeneca expects to deliver less than half the COVID-19 vaccines it was contracted to supply the European Union in the second quarter, an EU official told Reuters on Tuesday. Francesco Guarascio U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official
Log in or register to post comments

Institutional investors urge a more ‘fair and equitable’ international Covid-19 response

Tue, 2021-02-23 11:22 — mike kraft

Dozens of institutional investors push for 'equitable' Covid-19 response “The economic and financial damage triggered by Covid-19 knows no border,” said Marco Morelli, executive chairman of AXA Investment Managers. Ed Silverman STAT

Nearly 150 institutional investors that oversee combined assets worth more than $14 trillion have issued a joint call for a “fair and equitable” global response to the Covid-19 pandemic, and they intend to huddle with health care companies to make progress on that goal.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Institutional investors urge a more ‘fair and equitable’ international Covid-19 response
Log in or register to post comments

False claims that coronavirus vaccines can cause infertility drive doubts among women of childbearing age

Tue, 2021-02-23 10:58 — mike kraft

False claims tying coronavirus vaccines to infertility drive doubts among women of childbearing age Health officials worry their hesitation may affect efforts to reach immunization targets. Ariana Eunjung Cha Washington Post

As the rollout of the coronavirus vaccine ramps up across the United States, women of childbearing age have emerged as a surprising roadblock to efforts to halt the pandemic by achieving herd immunity.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

OVERVIEW: U.S. and International

Tue, 2021-02-23 10:39 — mike kraft

U.S and international COVID-related developments

ALSO SEE: Reuters worldwide roundup

SACRAMENTO, Calif. -- California lawmakers have cleared the way for 5.7 million people to get at least $600 in one-time payments, part of a state-sized coronavirus relief package aimed at helping lower-income people weather what they hope is the last legs of the pandemic.

The state Legislature passed the bill by a wide margin on Monday...

BUDAPEST — Officials in Hungary are urging people to trust in the vaccines already approved by the country ahead of a planned rollout Wednesday of a COVID-19 vaccine developed in China.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about OVERVIEW: U.S. and International
Log in or register to post comments

Differences between COVID-19 vaccines, summarized in a simple table

Mon, 2021-02-22 20:02 — mike kraft

All the differences between COVID-19 vaccines, summarized in a simple table that you can take to your vaccination appointment This summary table shows the differences among the COVID-19 vaccines from Pfizer-BioNTech, Moderna, and AstraZeneca-Oxford University. Dr. Catherine Schuster-Bruce Business Insider

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Differences between COVID-19 vaccines, summarized in a simple table
Log in or register to post comments

British data study says COVID-19 vaccines sharply cut hospitalizations

Mon, 2021-02-22 18:11 — mike kraft

LONDON (AP) — Two U.K. studies released Monday showed that COVID-19 vaccination programs are contributing to a sharp drop in hospitalizations, boosting hopes that the shots will work as well in the real world as they have in carefully controlled studies.

Preliminary results from a study in Scotland found that the Pfizer-BioNTech vaccine reduced hospital admissions by up to 85% four weeks after the first dose, while the Oxford-AstraZeneca shot cut admissions by up to 94%. In England, preliminary data from a study of health care workers showed that the Pfizer vaccine reduced the risk of catching COVID-19 by 70% after one dose, a figure that rose to 85% after the second.

“This new evidence shows that the jab protects you, and protects those around you,” U.K. Health Secretary Matt Hancock said. “It is important that we see as much evidence as possible on the vaccine’s impact on protection and on transmission and we will continue to publish evidence as we gather it.’’

Country / Region Tags:

General Topic Tags: